BIVDA and the MHRA recently featured a webinar which provided a global overview of IVDs in clinical genomic testing, a recording of which can be found here.
BIVDA were represented by our president and genomics expert Angela Douglas. With regulatory landscapes evolving across the UK, EU, and USA, staying informed is essential for compliance and market success.
The webinar covered those three countries in three expert-led talks (30 minutes each) covering key regulatory developments:
- US Perspectives – AMP members closely involved in the FDA lawsuit
- EU Insights – Speakers from BioMedAlliance
- UK Updates – Speakers from BIVDA and MHRA.
